RLIP76 and Cancer
- PMID: 18628450
- PMCID: PMC2919285
- DOI: 10.1158/1078-0432.CCR-08-0145
RLIP76 and Cancer
Abstract
RLIP76 is a multifunctional membrane protein that transports glutathione conjugates of electrophilic compounds and other xenobiotics including chemotherapy agents out of cells. The protein is overexpressed in lung carcinomas, ovarian carcinomas, and melanomas. The protein also binds Ral and participates in mitotic spindle function, clathrin-dependent endocytosis, and triggers GTPase-activating protein activity. It is found throughout the cell, in membrane, cytosol, and the nucleus, and is known to shift between these compartments in response to stress. Loss of RLIP76 by antibody or antisense therapy is associated with increased sensitivity to radiation and chemotherapy. Conversely, liposomally delivered RLIP may treat poisoning and wounds.
Conflict of interest statement
S. Awasthi has an ownership interest in Terapio.
Figures
References
-
- Ishii N, Ishii T, Hartman PS. The role of the electron transport SDHC gene on lifespan and cancer. Mitochondrion. 2007;7:24–8. - PubMed
-
- Okada F. Beyond foreign-body-induced carcinogenesis: impact of reactive oxygen species derived from inflammatory cells in tumorigenic conversion and tumor progression. Int J Cancer. 2007;121:2364–72. - PubMed
-
- Irminger-Finger I. Science of cancer and aging. J Clin Oncol. 2007;25:1844–51. - PubMed
-
- Davies KJ. An overview of oxidative stress. IUBMB Life. 2000;50:241–4. - PubMed
-
- Wallace DC. Mitochondria and cancer: Warburg addressed. Cold Spring Harbor Symp Quant Biol. 2005;70:363–74. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
